alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MA STERS

No. 17

- 568V

Filed: March 18, 2019

* * * * * * * * * * * * *

BEVERLY RAND

, * UNPUBLISHED

*

Petitioner, * Decision on Joint Stipulation;

* Guillain

- Barre Syndrome

v. * ( “ GBS ” ); Influenza ( “ Flu ” )

* Vaccine

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

*

Respondent. *

* * * * * * * * * * * * *

Ronald Homer, Esq.

, Conway, Homer, P.C., Boston

, MA

, for petitioner.

Amy Kokot

, Esq

. , US Department of Justice, Washington, DC, for respondent.

DECISION ON JOINT STIPULATION 1

Roth

, Special Master:

On April 26, 2017, Beverly Rand ( “ Ms. Rand or “petitioner”) filed a petition for

compensation under the National Vaccine Injury Compensation Program

. 2 Petitioner allege s that

she developed Guillain

- Barre Syndrome ( “ GBS ” ) after receiving an influenza ( “ flu ” ) vaccination

on or about September 29, 2015

. Stipulation, filed Mar. 18, 2019 , at ¶¶ 1

- 4. Respondent denies

that the afore mentioned immunizati on caused petitioner ’s injury. Stipulation at ¶ 6.

Nevertheless, the parties h ave agreed to settle the case. On March 18, 2019 , the parties

filed a joint stipulation agreeing to settle this case and describing the settlement terms.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the

Court of Federal Claims’s website, in accordance with the E

- Government Act of 2002, Pub. L. No. 107

- 347, 116 Stat. 2899, 2913 (codified as amended at 4 4 U.S.C. § 3501 note (2006)). This means the Decision

will be available to anyone with access to the internet. However, the parties may object to the Decision’s

inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party

has fourteen days within which to request redaction “of any information furnished by that party: (1) that is

a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes

medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of

privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id

.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99

- 660, 100 Sta t. 3755. Hereinafter, for ease

of citation, all “§” references to the Vaccine Act will be to the pertinent subpara graph of 42 U.S.C. § 300aa

(2012 ).

### 2

Responde nt agrees to issue the fol lowing payment :

A lump sum of $60,000.00 in the form of a check payable to petitioner, Beverly

Rand

. This amount represents compensation for all damages that would b e av ailable

under § 300aa

- 15(a).

I adopt the parties’ stipula tion attached hereto, and award compensation in the amount and

on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance

with this decision. 3

IT IS SO ORDERED.

s/ Mindy Michaels Roth

Mindy Michaels Roth

Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice

renouncing the right to seek review.
|   | 1. | The                Annual Report fully complies with the requirements of Section 13(a)                or                15(d) of the Securities Exchange Act of 1934;                and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The                information contained in this Annual Report fairly presents, in all                material respects, the financial condition and results of operation                of                UFood Restaurant Group, Inc. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                April 14, 2008 | /s/ Glenn Davis                                         |
|-------------------------------------|-------------------------------------------------------------------|
|                                | Glenn Davis                Chief Financial Officer |

----
1

Mears, Gilbert

From: Sheila Conry <sc@abender.com>

Sent: Wednesday, July 09, 2014 6:13 PM

To: Mears, Gilbert

Subject: Docket #: EPA-HQ-TRI-2013-0281 

Follow Up Flag: Follow up

Flag Status: Flagged

Hello, Mr. Means, 

The Toxics Release Inventory loophole needs to be closed. It is outrageous that the citizenry is being run 

over by the fossil fuel industry and kept in the dark about the deleterious toxins that are being released 

into our environment. 

Thank you for your consideration. 

Cordially,

Sheila Conry 

328 Highland Lane 

Edgeworth, PA 15143 

412.656.1058 cell
IIA 

118TH CONGRESS 

2D SESSION S. J. RES. 82 

Providing for congressional disapproval under chapter 8 of title 5, United 

States Code, of the rule submitted by the Food and Drug Administration 

relating to ‘‘Medical Devices; Laboratory Developed Tests’’. 

IN THE SENATE OF THE UNITED STATES 

MAY 15, 2024 

Mr. PAUL introduced the following joint resolution; which was read twice and 

referred to the Committee on Health, Education, Labor, and Pensions 

JOINT RESOLUTION 

Providing for congressional disapproval under chapter 8 of 

title 5, United States Code, of the rule submitted by 

the Food and Drug Administration relating to ‘‘Medical 

Devices; Laboratory Developed Tests’’. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That Congress disapproves the rule submitted by the Food 

4 and Drug Administration relating to ‘‘Medical Devices; 

5 Laboratory Developed Tests’’ (89 Fed. Reg. 37286 (May 

6 6, 2024)), and such rule shall have no force or effect. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
#### In the Matter of the Administration of the Estate of Arthur Wells, Deceased. Ella Rykert, Appellant; Emma Wells, Respondent.

*Matter of Wells,*133 App. Div. 79, affirmed.

(Argued January 6, 1909;

decided January 26, 1909.)

Appeal from an order of the Appellate Division of the Supreme Court in the fourth judicial department, entered January 8, 1908, which reversed a decree of the Niagara County Surrogate’s Court revoking letters of administration theretofore issued on the estate of Arthur Wells, deceased.

*Robert II. Gittins*for appellant.

*Frank F. Williams*for respondent.

Order affirmed, with costs; no opinion.

Concur: Cullen, Ch. J., Edward T. Bartlett, Vann, Werner, Willard Bartlett, Hiscock and Chase, JJ.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S.J. Res. 62 Placed on Calendar Senate (PCS)]

<DOC>

                                                       Calendar No. 340
118th CONGRESS
  2d Session
S. J. RES. 62

  Providing for congressional disapproval under chapter 8 of title 5, 
   United States Code, of the rule submitted by the Animal and Plant 
Health Inspection Service relating to ``Importation of Fresh Beef From 
                              Paraguay''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 26, 2024

 Mr. Tester (for himself, Mr. Rounds, Ms. Rosen, Mr. Moran, Mr. Brown, 
 Mr. Cramer, Ms. Lummis, Ms. Cortez Masto, Mr. Manchin, Mr. Ricketts, 
and Mr. Marshall) introduced the following joint resolution; which was 
read twice and referred to the Committee on Agriculture, Nutrition, and 
                                Forestry

                             March 11, 2024

  Committee discharged by petition, pursuant to 5 U.S.C. 802(c), and 
                         placed on the calendar

_______________________________________________________________________

                            JOINT RESOLUTION

 
  Providing for congressional disapproval under chapter 8 of title 5, 
   United States Code, of the rule submitted by the Animal and Plant 
Health Inspection Service relating to ``Importation of Fresh Beef From 
                              Paraguay''.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That Congress disapproves the 
rule submitted by the Animal and Plant Health Inspection Service 
relating to ``Importation of Fresh Beef From Paraguay'' (88 Fed. Reg. 
77883 (November 14, 2023)), and such rule shall have no force or 
effect.

                                                       Calendar No. 340

118th CONGRESS

  2d Session

                             S. J. RES. 62

_______________________________________________________________________

                            JOINT RESOLUTION

  Providing for congressional disapproval under chapter 8 of title 5, 
   United States Code, of the rule submitted by the Animal and Plant 
Health Inspection Service relating to ``Importation of Fresh Beef From 
                              Paraguay''.

_______________________________________________________________________

                             March 11, 2024

  Committee discharged by petition, pursuant to 5 U.S.C. 802(c), and 
                         placed on the calendar
```
<PAGE>

                                                                    EXHIBIT 32.2

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of RTI International Metals, Inc.
(the "Company") on Form 10-Q for the period ended June 30, 2005 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Lawrence W. Jacobs, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
act of 2002, that:

          (3) The Report fully complies with the requirements of section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

          (4) The information contained in the Report fairly presents, in all
     material respects, the financial condition and result of operations of the
     Company.

August 9, 2005

      /s/ LAWRENCE W. JACOBS
--------------------------------------
          Lawrence W. Jacobs
       Chief Financial Officer

* This certification is made solely for the purposes of 18 U.S.C. Section 1350,
  subject to the knowledge standard contained therein, and not for any other
  purpose.
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           3,833
<INT-BEARING-DEPOSITS>                          61,376
<FED-FUNDS-SOLD>                                10,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      4,564
<INVESTMENTS-CARRYING>                           4,564
<INVESTMENTS-MARKET>                             4,564
<LOANS>                                         58,809
<ALLOWANCE>                                        796
<TOTAL-ASSETS>                                  78,577
<DEPOSITS>                                      70,820
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                413
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,190
<OTHER-SE>                                     (2,846)
<TOTAL-LIABILITIES-AND-EQUITY>                  78,577
<INTEREST-LOAN>                                  2,480
<INTEREST-INVEST>                                  134
<INTEREST-OTHER>                                   297
<INTEREST-TOTAL>                                 2,911
<INTEREST-DEPOSIT>                               1,633
<INTEREST-EXPENSE>                               1,633
<INTEREST-INCOME-NET>                            1,278
<LOAN-LOSSES>                                       85
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  1,685
<INCOME-PRETAX>                                  (428)
<INCOME-PRE-EXTRAORDINARY>                       (428)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (428)
<EPS-BASIC>                                     (0.57)
<EPS-DILUTED>                                   (0.57)
<YIELD-ACTUAL>                                    3.83
<LOANS-NON>                                      1,450
<LOANS-PAST>                                        43
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   715
<CHARGE-OFFS>                                        4
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  796
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
EXHIBIT 31.1



CERTIFICATIONS



I, David (Xiaoying) Gao, certify that:



| | 1. | I have reviewed this Amendment No.1 to the Annual Report on Form 10-K of China Biologic Products, Inc.; and
| | -- | -----------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date: November 2, 2016



|/s/ David (Xiaoying) Gao      | 
|----------------------------- | 
|David (Xiaoying) Gao          | 
|Chief Executive Officer       | 
|(Principal Executive Officer) |
#### § 1336.30 Eligibility under sections 804 and 805 of the Native American Programs Act of 1974.

Financial assistance under sections 804 and 805 may be made to public or private agencies including “for-profit” organizations.

[48 FR 55821, Dec. 15, 1983, as amended at 53 FR 23968, June 24, 1988; 53 FR 28223, July 27, 1988; 54 FR 3452, Jan. 24, 1989; 61 FR 42820, Aug. 19, 1996]
**EXHIBIT 32.2**

 

**CERTIFICATIONS OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of GTJ REIT, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2008 as filed with the Securities and Exchange Commission (the “Periodic Report”), I, David Oplanich, Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the            Sarbanes-Oxley Act of 2002, that:

1. the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

| Date: March 31, 2009 | /s/ David J. Oplanich                      |
|----------------------|--------------------------------------------|
|                 | David J. Oplanich

Chief Financial Officer |
**
**Exhibit 31.3**

**Certification of Principal Executive Officer**

I, Patrick J. McEnany, certify that: 

 
1.
I have reviewed this Form 10-K/A of Catalyst Pharmaceuticals, Inc.; and

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. 

 
Date: April 29, 2020
/s/ Patrick J. McEnany
Patrick J. McEnanyChief Executive Officer(Principal Executive Officer)**
Exhibit 8.1

LIST OF SUBSIDIARIES OF GENESIS LEASE LIMITED (UNAUDITED)

Entity


Direct parent


JurisdictionGenesis Lease Limited (‘‘GLS’’)


—


BermudaGenesis Funding Limited (‘‘GFL’’)


GLS


BermudaGenesis Acquisition Limited (‘‘GAL’’)


GLS


BermudaGLS Atlantic Alpha Limited (‘‘GLS Atlantic’’)


GLS


BermudaWestpark 1 Aircraft Leasing Limited


GLS


BermudaGLS Norway Alpha AS


GLS Atlantic


NorwayGenesis Ireland Aviation Trading 1 Limited


GFL


IrelandGenesis Ireland Aviation Trading 2 Limited


GFL


IrelandGenesis Ireland Aviation Trading 3 Limited


GFL


IrelandGenesis Ireland Aviation Trading 4 Limited


GFL


IrelandGenesis Funding France 1 SARL


GFL


FranceGenesis Funding France 2 SARL


GFL


FranceGenesis Funding Sweden I AB


GFL


SwedenGenesis Leasing USA Inc


GFL


USAGFL Aircraft Leasing Netherlands BV


GFL


NetherlandsGenesis Funding Norway 1 AS


GFL


NorwayGenesis China Leasing 1 Limited


GFL


BermudaGenesis China Leasing 2 Limited


GFL


BermudaRoss Leasing Limited


GAL


BermudaLare Leasing Limited


GAL


BermudaRoselawn Leasing Limited


GAL


BermudaCratloe Leasing Limited


GAL


BermudaSalthill Leasing Limited


GAL


BermudaCastletroy Leasing Limited


GAL


Ireland


---
# Comimmiiotion s

r rN T E R

. rrr g STATIO N P.O . Bo x86 8 Franklin , P

A 1632 3 C - 814-437-104 9 C • • 800-373-775 0 http://www.commctr.co m

Jul y19 , 201 Q Chief , Essentia l Servic e Dis t X-5 3 Offic e o f Aviatio n Analytic s US Dept . o f Transportatio n 120 0 Ne w Jerse yAvenue , S E Washington , D

C 2059 0 Dea rMr . DeVaney , W e ar e a smal l busines s locate d i n Franklin , P A an d ar e writin g t o infor m yo u o f ou rsuppor t t o Optio n 1 o f Gulfstrea m International' s proposa l t o continu e offerin g essentia l ai rservic e t o ou rcommunity . W e ma yno t trave l as frequentl yas som e large rbusinesses , bu t fee l tha t th e loca l ai rtrave l optio n i s importan t an d w e wil l commi t t o usin g ou rloca l servic e provide d b yGulfstrea m Internationa l wheneve r possible . Thi s servic e i s a grea t asse t t o ou rcommunity . Than k yo u fo ryou rtime .

GaryMoys e
#### H. Linsly Johnson, as Trustee, in Bankruptcy of Franklin Typewriter Company, Respondent, *v.*Levi L. Tower et al., Appellants, Impleaded with Another.

*Gove*v. *Morton Trust Go.,*122 App. Div. 916, affirmed.

(Argued January 11, 1909;

decided January 26, 1909.)

Appeal, by permission, from a judgment of the Appellate Division of the Supreme Court in the first judicial department, entered December 9, 1907, unanimously affirming a *553judgment in favor of plaintiff entered upon a decision of the court on trial at Special Term in an action to set aside a certain deed of trust covering personal property of the bankrupt herein.

*Charles Howard Williams, Howard H. Williams*and *James D. Williams*for appellants.

*John R. Abney*for respondent.

Judgment affirmed, with costs ; no opinion.

Concur: Cüllen, Ch. J., Edward T. Bartlett, Vann, Werner, Willard Bartlett, Hiscock and Chase, JJ.
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

	NO. 2-05-218-CV

GRADY ALLEN DAVIS	APPELLANT

	V.

STATE OF TEXAS	APPELLEE

	----------

	FROM THE 362ND DISTRICT COURT OF DENTON COUNTY

	----------

	MEMORANDUM OPINION1 AND JUDGMENT

	----------

	On June 9, 2005, Appellant Grady Allen Davis filed a notice of appeal seeking to appeal from the trial court’s denial of his petition for expunction of his records in the underlying criminal case.  On  August 3, 2005, Appellant notified this court of his desire to set aside this appeal.  Accordingly, we dismiss this appeal.  See Tex. R. App. P. 42.1(a)(1). 

								PER CURIAM	

PANEL B:	HOLMAN, GARDNER, and WALKER, JJ.

DELIVERED: August 18, 2005
§ 1609.2 Definitions. ( a ) *Fee-generating case* means any case or matter which, if undertaken on behalf of an eligible client by an attorney in private practice, reasonably may be expected to result in a fee for legal services from an award to a client.
( b ) *Fee-generating case* does not include a case where: ( 1 ) A court appoints a recipient or an employee of a recipient to provide representation in a case pursuant to a statute or a court rule or practice equally applicable to all attorneys in the jurisdiction;
( 2 ) A recipient undertakes representation under a contract with a government agency or other entity; or
( 3 ) A recipient provides only advice and counsel or limited services, as those terms are defined in 45 CFR 1611.1(a) and (e), to an eligible client.
[62 FR 19399, Apr. 21, 1997, as amended at 82 FR 20446, May 2, 2017]
#### § 1225.14 Consolidation of complaints.

The EEOP Director may consolidate the complaint if it involves the same or sufficiently similar allegations as those contained in a previous complaint filed on behalf of the same class which is pending in the agency or which had been resolved or decided by the agency.